Natural Products in the Management of Gastroesophageal Reflux Disease: Mechanisms, Efficacy, and Future Directions
- PMID: 40292509
- PMCID: PMC11944625
- DOI: 10.3390/nu17061069
Natural Products in the Management of Gastroesophageal Reflux Disease: Mechanisms, Efficacy, and Future Directions
Abstract
Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder that is defined by the reflux of gastric contents into the esophagus, and it results in symptoms such as esophageal inflammation, regurgitation, and indigestion. Although proton pump inhibitors (PPIs) and histamine-2 receptor antagonists are frequently employed to treat GERD, their prolonged administration is associated with adverse effects, necessitating the development of alternative therapeutic strategies. Natural products are now recognized as promising candidates for the management of GERD due to their bioactive compounds, which possess antioxidant, anti-inflammatory, and mucosal-protective properties. The potential of natural products in the treatment of GERD is comprehensively examined in this review, with a focus on their mechanisms of action, which include acid suppression, esophageal mucosal regeneration, anti-inflammatory activity, and gut microbiota modulation. Also, the efficacy and safety of key natural products, including flavonoids, polyphenols, plant-derived oils, herbal extracts, probiotics, and dietary components, in preclinical and clinical studies, are assessed. Additionally, this review addresses the barriers confronting the translation of natural therapies into clinical practice, such as regulatory obstacles, variability in bioavailability, and the need for dosage standardization. The integration of natural products into the management of GERD has the potential to enhance conventional therapies, providing a more comprehensive and secure approach for patients.
Keywords: GERD; anti-inflammatory; gastroesophageal; natural products; reflux disease.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.Genomics Proteomics Bioinformatics. 2019 Feb;17(1):52-63. doi: 10.1016/j.gpb.2018.12.004. Epub 2019 Apr 25. Genomics Proteomics Bioinformatics. 2019. PMID: 31028880 Free PMC article.
-
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.Clin Gastroenterol Hepatol. 2022 May;20(5):984-994.e1. doi: 10.1016/j.cgh.2022.01.025. Epub 2022 Feb 2. Clin Gastroenterol Hepatol. 2022. PMID: 35123084 Free PMC article. Review.
-
Medicinal Plants for Management of Gastroesophageal Reflux Disease: A Review of Animal and Human Studies.J Altern Complement Med. 2017 Feb;23(2):82-95. doi: 10.1089/acm.2016.0233. Epub 2016 Dec 20. J Altern Complement Med. 2017. PMID: 27996295 Review.
-
Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.Expert Opin Pharmacother. 2010 Jun;11(9):1541-8. doi: 10.1517/14656566.2010.482932. Expert Opin Pharmacother. 2010. PMID: 20450445 Review.
-
Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.J Pediatr (Rio J). 2014 Mar-Apr;90(2):105-18. doi: 10.1016/j.jped.2013.05.009. Epub 2013 Oct 30. J Pediatr (Rio J). 2014. PMID: 24184302 Review.
Cited by
-
The association between GERD symptoms severity and psychosocial health in palestine: a cross-sectional study.BMC Res Notes. 2025 Aug 17;18(1):357. doi: 10.1186/s13104-025-07449-z. BMC Res Notes. 2025. PMID: 40820143 Free PMC article.
References
-
- Antunes C., Aleem A., Curtis S.A. Gastroesophageal Reflux Disease. StatPearls Publishing; Treasure Island, FL, USA: 2025. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical